A Study of Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder Cancer

Clinical trial NCT05567185 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05567185
Sponsor: Janssen Pharmaceutical K.K.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Urinary Bladder Neoplasms Receptors, Fibroblast Growth Factor

Start date: 2023-03-03
Primary completion: 2025-03-11
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.